Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5721-5724
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5721
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5721
HLA | Responder | Non-responder | OR (95%CI) | P | ||
N1 | Allele frequencyn = 22 | N2 | Allele frequencyn = 48 | |||
DRB1*01 | 0 | 0 | 1 | 2.08 | 1.468 (1.249–1.725) | 1.000 |
DRB1*04 | 2 | 9.09 | 7 | 14.58 | 0.586 (0.111–3.080) | 0.709 |
DRB1*06 | 0 | 0 | 1 | 2.08 | 1.468 (1.249–1.725) | 1.000 |
DRB1*07 | 1 | 4.55 | 2 | 4.17 | 1.095 (0.094–12.760) | 1.000 |
DRB1*08 | 2 | 9.09 | 3 | 6.25 | 1.500 (0.232–9.685) | 0.646 |
DRB1*09 | 3 | 13.64 | 11 | 22.92 | 0.531 (0.132–2.135) | 0.524 |
DRB1*10 | 1 | 4.55 | 2 | 4.17 | 1.095 (0.094–12.760) | 1.000 |
DRB1*11 | 1 | 4.55 | 5 | 10.42 | 0.410 (0.045–3.731) | 0.657 |
DRB1*12 | 2 | 9.09 | 9 | 18.75 | 0.433 (0.085–2.199) | 0.483 |
DRB1*14 | 4 | 18.18 | 1 | 2.08 | 10.444 (1.092–99.855) | 0.031 |
DRB1*15 | 2 | 9.09 | 1 | 2.08 | 4.700 (0.403–54.835) | 0.231 |
DRB1*16 | 3 | 13.64 | 2 | 4.17 | 3.632 (0.561–23.500) | 0.316 |
DRB1*17 | 1 | 4.55 | 3 | 6.25 | 0.714 (0.070–7.281) | 1.000 |
DQB1*02 | 2 | 9.09 | 3 | 6.25 | 1.500 (0.232–9.685) | 0.646 |
DQB1*04 | 1 | 4.55 | 1 | 2.08 | 2.238 (0.134–37.516) | 0.533 |
DQB1*05 | 7 | 31.82 | 8 | 16.67 | 2.333 (0.720–7.557) | 0.210 |
DQB1*06 | 4 | 18.18 | 2 | 4.17 | 5.111 (0.860–30.310) | 0.073 |
DQB1*07 | 2 | 9.09 | 18 | 37.5 | 0.167 (0.035–0.796) | 0.021 |
DQB1*08 | 1 | 4.55 | 5 | 10.42 | 0.410 (0.045–3.731) | 0.657 |
DQB1*09 | 5 | 22.73 | 11 | 22.92 | 0.989 (0.297–3.295) | 1.000 |
- Citation: Han YN, Yang JL, Zheng SG, Tang Q, Zhu W. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J Gastroenterol 2005; 11(36): 5721-5724
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5721.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5721